Dexco SA (DXCO3) Financial Statements
Dexco SA Financial Overview
Dexco SA's market cap is currently $4.08B. The company's EPS TTM is $-0.04; its P/E ratio is -119.32; and it has a dividend yield of 0.95%. Dexco SA is scheduled to report earnings on November 4, 2026, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 8.25B | $ 8.23B | $ 7.38B | $ 8.49B | $ 8.17B |
| Gross Profit | $ 1.64B | $ 2.45B | $ 2.38B | $ 2.87B | $ 2.87B |
| Operating Income | $ 182.72M | $ 928.98M | $ 1.27B | $ 1.45B | $ 2.06B |
| EBITDA | $ 1.44B | $ 2.45B | $ 2.43B | $ 2.68B | $ 2.99B |
| Net Income | $ 1.18M | $ 172.41M | $ 789.60M | $ 755.86M | $ 1.73B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.53B | $ 1.75B | $ 2.79B | $ 1.77B | $ 1.42B |
| Total Assets | $ 19.00B | $ 18.14B | $ 17.97B | $ 15.62B | $ 13.42B |
| Total Debt | $ 8.48B | $ 7.25B | $ 7.72B | $ 6.20B | $ 4.27B |
| Net Debt | $ 7.90B | $ 6.02B | $ 4.93B | $ 4.43B | $ 2.85B |
| Total Liabilities | $ 11.79B | $ 10.95B | $ 11.45B | $ 9.66B | $ 7.69B |
| Stockholders' Equity | $ 6.85B | $ 6.98B | $ 6.40B | $ 5.87B | $ 5.73B |
| Cash Flow | |||||
| Free Cash Flow | $ -60.32M | $ -63.66M | $ 97.62M | $ -419.41M | $ 851.12M |
| Operating Cash Flow | $ 850.65M | $ 1.28B | $ 1.35B | $ 793.69M | $ 1.71B |
| Investing Cash Flow | $ -620.02M | $ -1.98B | $ -1.30B | $ -1.64B | $ -1.07B |
| Financing Cash Flow | $ 708.99M | $ -882.55M | $ 960.46M | $ 1.23B | $ -942.35M |
Currency in BRL